Afinitor 10 mg tablets, Aromasin 25 mg coated tablets, Faslodex 250 mg solution for injection., Afinitor 5 mg tablets
C4391022
Phase 3 small_molecule active
Quick answer
Afinitor 10 mg tablets, Aromasin 25 mg coated tablets, Faslodex 250 mg solution for injection., Afinitor 5 mg tablets for Hormone receptor-positive, her2-negative advanced/metastatic breast cancer is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Hormone receptor-positive, her2-negative advanced/metastatic breast cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active